Teva Pharmaceutical Industries will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the US opioid epidemic.
Wolt announced that it has partnered with Be Pharma in order to offer non-prescription drugs with immediate delivery in under an hour.
Erroca has an annual sales turnover of approximately NIS 100 million through its 60 branches.
The EU-GMP certification is essential in order to create, export and market any type of medicine in Europe, including medical cannabis.
Australian pharma giant Chemist Warehouse is in the advanced stages of considering expansion into the Israeli market.
The litigation has resulted in several nationwide settlements, including a $4.25 billion settlement with Israel-based Teva Pharmaceutical Industries
Early startup AvoMed has developed a way to use the whole buffalo (or in this case, the whole avocado) to develop effective skin damage treatments.
Revenue from the antiviral pill, Paxlovid, exceeded market estimates by more than $1b, while vaccine sales surged 20%, helping the drugmaker reaffirm the combined 2022 revenue forecast of $54b.
The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.
Should the pharmaceutical industry be lauded or lambasted for the drugs that they've developed? Or is there a middle path for the industry to take?